Ocular Therapeutix Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Ocular Therapeutix Stock Summary

Ocular Therapeutix competes with CytomX Therapeutics, Assembly Biosciences, Spero Therapeutics, Achilles Therapeutics, and Terns Pharmaceuticals. Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts. Ocular Therapeut operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 228 people.

Ocular Therapeutix Key Financial Ratios

Ocular Therapeutix Key Balance Sheet Accounts

Ocular Therapeutix Key Income Statement Accounts

Ocular Therapeutix Key Cash Accounts

Ocular Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ocular Therapeutix's current stock value. Our valuation model uses many indicators to compare Ocular Therapeutix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ocular Therapeutix competition to find correlations between indicators driving Ocular Therapeutix's intrinsic value. More Info.Ocular Therapeutix is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Ocular Therapeutix's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Ocular Therapeutix by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Ocular Therapeutix Systematic Risk

Today, most investors in Ocular Therapeutix Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ocular Therapeutix's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Ocular Therapeutix growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Ocular Therapeutix help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ocular Therapeutix. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ocular Therapeutix based on widely used predictive technical indicators. In general, we focus on analyzing Ocular Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ocular Therapeutix's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocular Therapeutix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For more information on how to buy Ocular Stock please use our How to buy in Ocular Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocular Therapeutix. If investors know Ocular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocular Therapeutix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Ocular Therapeutix is measured differently than its book value, which is the value of Ocular that is recorded on the company's balance sheet. Investors also form their own opinion of Ocular Therapeutix's value that differs from its market value or its book value, called intrinsic value, which is Ocular Therapeutix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocular Therapeutix's market value can be influenced by many factors that don't directly affect Ocular Therapeutix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Ocular Therapeutix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocular Therapeutix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocular Therapeutix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.